Dallas Hair Loss Treatment
Hair loss in both men and women is becoming worse and worse every year as toxins in our environment, hormones in our food and other factors act to destroy the sensitive hair follicles that nourish healthy hair. It isn’t just about genetics anymore…hair loss can happen to most anyone regardless of their family history. It affects men whether it be a receding hairline, classic male pattern baldness, or other forms of hair loss. Drugs like Propecia or Minoxodil may help slightly, but come with significant side effects and require you take them for life. Thousands of potions and lotions on the market claim to help with hair regrowth, but if any one really worked (with science to back it up) the medical community would have embraced them. Hair restoration surgery can cost an average of $15,000 each time, and possibly requires multiple surgeries. For millions of Texans in Dallas or elsewhere who suffer with hair loss, it is simply something they have to live with.
Laser Hair Treatment with the Revåge 670™
Now the Revåge 670™ laser hair treatment provides a scientifically proven hair loss treatment that provides hope for those without highly advanced hair loss. The Revåge 670™ laser works through a rotating canopy of laser light that evenly treats your entire scalp while you sit comfortably resting. The “cold” laser light provides Low-Level Laser Light (LLLL) therapy that stimulates the scalp, increasing blood flow to the hair follicles. This increases cellular metabolism, promoting the repair of damaged cells and weakened hair follicles and leading to the cessation of hair loss and the stimulation of hair regrowth. The Revåge 670™ is/offers:
- Safe
- Painless
- Non-surgical
- No short or long-term side effects
- FDA cleared
- Easy 20 minute treatment while sitting
After the first 3-6 months of treatment, 80 percent of patients with AGA-related (or Androgenetic Alopecia) hair loss report increased hair density, and nearly all patients with telogen effluvium (more generalized hair loss in women) report that shedding has completely stopped. The Revåge 670™ has been scientifically proven* by the leading institutions to STOP HAIR LOSS AND REGENERATE HAIR.
Women's Hair Loss Treatment
Hair loss in women (although perhaps less talked about then baldness and hair loss in men) is becoming increasingly common and is much more prevalent than many think. Female hair loss tends to be more diffuse in its pattern and often involves shedding and thinning rather than the classic male pattern ‘bald spot’. With today’s more toxic environment, more women are experiencing hair loss due to stress, childbirth, menopause or other stress and hormonal factors. The Revåge 670™ laser helps treat women’s hair loss by offering a broad coverage pattern with its canopy of laser light that treats the entire scalp and helps to stop shedding and reduce thinning. Most women wish for the bouncy hair of shampoo commercials and our laser hair treatment can help get you there!
The Revåge 670™ on ‘The Doctors’
Hair Loss Treatment for Cancer Patients
Patients experiencing hair loss due to chemotherapy or other cancer treatments are often directed to get wigs or wear hats. Now you have another option and can simultaneously fight to keep your healthy appearance (and confidence) intact with the painless, non-surgical laser hair treatment of the Revåge 670™. Without any required systemic drugs nor any surgical risk, laser hair treatment is gentle enough for most patients to tolerate.
Contact BellaMD today for your free consultation. Dr. Engleman will be able to quickly tell you if you are a suitable candidate for the procedure and likely to see results. Through use of a microscopic camera, he will be able to determine the exact state of your hair follicles and let you know whether they are dormant (can respond to treatment) or dead (treatment won’t work), and will work with you to recommend an appropriate hair loss treatment plan.
Revåge 670™ is a trademark of Apira Science (Newport Beach, CA)
*Harvard Medical, Northwestern University, Mass General and many more top institutions
